#Ep 5: The Consistent Compounders Show :Stay tuned to catch Saurabh Mukherjea in conversation with Sohini Andani, Fund Manager, SBI Mutual Fund.

Cadila Healthcare Q2 PAT may dip 23% YoY to Rs. 321.5 cr: Emkay

Net Sales are expected to increase by 17.4 percent Y-o-Y (down 0.6 percent Q-o-Q) to Rs. 3,475.2 crore, according to Emkay.

October 14, 2019 / 03:49 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Emkay has come out with its second quarter (July-September’ 19) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Cadila Healthcare to report net profit at Rs. 321.5 crore down 23% year-on-year (up 6% quarter-on-quarter).


Net Sales are expected to increase by 17.4 percent Y-o-Y (down 0.6 percent Q-o-Q) to Rs. 3,475.2 crore, according to Emkay.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 5 percent Y-o-Y (up 4 percent Q-o-Q) to Rs. 655.6 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol News

stay updated

Get Daily News on your Browser
Sections